Tsukuba, Japan

Tomoharu Iino

USPTO Granted Patents = 12 



Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Tsukuba, JP (2003 - 2012)
  • Tokyo, JP (2012)
  • Koto-Ku, JP (2013 - 2014)

Company Filing History:


Years Active: 2003-2014

where 'Filed Patents' based on already Granted Patents

12 patents (USPTO):

Title: The Innovative Contributions of Tomoharu Iino

Introduction

Tomoharu Iino is a noted inventor based in Tsukuba, Japan, with a significant impact in the pharmaceutical field. He has an impressive portfolio of 12 patents, showcasing his commitment to addressing critical health issues such as diabetes and obesity through innovative solutions.

Latest Patents

Among his notable inventions are two recent patents that focus on compounds designed to activate glucokinase, making them valuable in treating diabetes and related conditions. The first patent involves heteroaryl quinazoline derivatives, where compounds are described with a specific formula that indicates various structural features, including a pyrazolyl group and a heteroaryl group. The compounds are beneficial in developing medicines for diabetic treatment. The second patent details an oxotetrahydrofuran-2-yl-benzimidazole derivative, which is also geared towards the treatment and prevention of diabetes mellitus and its complications. These compounds manifest glucokinase-activating effects and are presented in a comprehensive structural formula.

Career Highlights

Tomoharu Iino has worked with reputable companies, including MSD K.K. and Banyu Pharmaceutical Co. Ltd., where he greatly contributed to the advancement of pharmaceutical research and development. His work has been pivotal in exploring therapeutic avenues for chronic conditions, reinforcing his role as an innovative device in the medical arena.

Collaborations

Throughout his career, Iino has collaborated with distinguished colleagues, including Teruyuki Nishimura and Jun-ichi Eiki. These partnerships have fostered an environment of creativity and innovation, allowing them to explore new scientific frontiers and product development in their shared endeavors.

Conclusion

In summary, Tomoharu Iino is a distinguished inventor whose patents play a crucial role in the ongoing fight against diabetes and obesity. His innovative compounds highlight the importance of research in creating effective treatments, underscoring his significance in the pharmaceutical landscape and his contributions toward better health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…